MarketBeat Instant News Alerts 2 hours agoEikon Therapeutics Eyes 2027 Melanoma Trial Update, With Key Cancer Data Expected in 2029MarketBeatEikon Therapeutics (NASDAQ:EIKN) expects an interim analysis of its lead melanoma study in the first half of 2027 and estimates that definitive data from that trial and a lung cancer study could be available around the middle of 2029, CEO Roger Perlmutter said during a JPMorgan biotech call. Both sNASDAQ:EIKNRead Eikon Therapeutics Eyes 2027 Melanoma Trial Update, With Key Cancer Data Expected in 20292 hours agoAir Products and Chemicals Q4 Earnings Call HighlightsMarketBeatAir Products and Chemicals (NYSE:APD) forecast adjusted earnings growth of 5% to 8% in fiscal 2027, as the industrial gases company shifts spending toward its core business and works to complete legacy energy transition projects. The outlook followed a fiscal 2026 in which sales rose 8% and adjusteNYSE:APDRead Air Products and Chemicals Q4 Earnings Call Highlights2 hours agoZai Lab Q3 Earnings Call HighlightsMarketBeatZai Lab (NASDAQ:ZLAB) reported $108.2 million in third-quarter revenue and said it expects to return to year-over-year product revenue growth in 2027, while advancing its lead cancer drug candidate toward potential U.S. regulatory submissions next year. Founder, CEO and Chairperson Samantha Du saidNASDAQ:ZLABRead Zai Lab Q3 Earnings Call Highlights2 hours agoArtivion Q3 Earnings Call HighlightsMarketBeatArtivion (NYSE:AORT) reported 9% constant-currency revenue growth in the third quarter of 2026, while adjusted earnings declined as the medical device maker invested in manufacturing and prepared for the U.S. launch of its NEXUS aortic repair system. Revenue rose to $123.8 million, with growth led NYSE:AORTRead Artivion Q3 Earnings Call Highlights2 hours agoAlpha Metallurgical Resources Q3 Earnings Call HighlightsMarketBeatAlpha Metallurgical Resources (NYSE:AMR) reported higher third-quarter shipments and adjusted earnings, while laying out a 2027 shipping plan that accounts for prolonged repairs at a key export terminal. The metallurgical coal producer shipped 3.9 million tons in the third quarter of 2026, up from NYSE:AMRRead Alpha Metallurgical Resources Q3 Earnings Call Highlights2 hours agoWhat Verastem (VSTM) Said on Its Q3 Earnings CallMarketBeatVerastem (NASDAQ:VSTM) reported $24 million in third-quarter 2026 net product revenue as refills of its ovarian cancer treatment offset a moderation in new patient starts. The company also outlined plans to begin a late-stage pancreatic cancer trial for its experimental drug VS-7375 by year-end. ReNASDAQ:VSTMRead What Verastem (VSTM) Said on Its Q3 Earnings Call Trending News1Fermi Advances Project Matador, Pivots to Powered-Land Strategy as Director Vote Fails220,118 AST SpaceMobile, Inc. $ASTS Shares Acquired by International Assets Investment Management LLC3Compass Pathways (NASDAQ:CMPS) Stock Falls 7.1% - Should You Sell?4Apple Q4 Earnings Call Highlights5NVIDIA (NASDAQ:NVDA) Stock Falls 3.2% - Time to Sell?6110,309 Shares of MNTN Inc. $MNTN Bought by One Way Holdings LLC7Trisura Group (TSE:TSU) Hits New 52-Week Low - Here's Why8Sable Offshore (SOC) Projected to Post Earnings on Monday All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 5 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Corporate Event Transcript Dividend Earnings Earnings Preview Earnings Transcript Highlights Estimates Guidance Insider Trade Lockup Expiration MarketBeat List Articles Options Price SEC Filing Stock List Stock Split Alert Type Keywords More filters Fewer filters Done 2 hours agoVSE Q3 Earnings Call HighlightsMarketBeatNASDAQ:VSECRead VSE Q3 Earnings Call Highlights2 hours agoViasat Q2 Earnings Call HighlightsMarketBeatNASDAQ:VSATRead Viasat Q2 Earnings Call Highlights2 hours agoWhat Verisk Analytics (VRSK) Said on Its Q3 Earnings CallMarketBeatNASDAQ:VRSKRead What Verisk Analytics (VRSK) Said on Its Q3 Earnings Call2 hours agoViemed Healthcare Q3 Earnings Call HighlightsMarketBeatNASDAQ:VMDRead Viemed Healthcare Q3 Earnings Call Highlights2 hours agoAnthem (NASDAQ:ANTX) Insider Joshua Eizen Sells 2,826 Shares of StockMarketBeatNASDAQ:ANTXRead Anthem (NASDAQ:ANTX) Insider Joshua Eizen Sells 2,826 Shares of Stock2 hours agoInsider Selling: GlobalFoundries (NASDAQ:GFS) Insider Sells $13,004.70 in StockMarketBeatNASDAQ:GFSRead Insider Selling: GlobalFoundries (NASDAQ:GFS) Insider Sells $13,004.70 in Stock2 hours agoCullinan Therapeutics (NASDAQ:CGEM) Insider Jennifer Michaelson Sells 4,000 Shares of StockMarketBeatNASDAQ:CGEMRead Cullinan Therapeutics (NASDAQ:CGEM) Insider Jennifer Michaelson Sells 4,000 Shares of Stock2 hours agoSiBone (NASDAQ:SIBN) Stock: Insider Anshul Maheshwari Sells 3,247 SharesMarketBeatNASDAQ:SIBNRead SiBone (NASDAQ:SIBN) Stock: Insider Anshul Maheshwari Sells 3,247 Shares2 hours agoLigand Pharmaceuticals (NASDAQ:LGND) Director Sells 282 Shares of Company StockMarketBeatNASDAQ:LGNDRead Ligand Pharmaceuticals (NASDAQ:LGND) Director Sells 282 Shares of Company Stock2 hours agoPROCEPT BioRobotics (NASDAQ:PRCT) Insider Pooja Sharma Sells 4,710 Shares of Company StockMarketBeatNASDAQ:PRCTRead PROCEPT BioRobotics (NASDAQ:PRCT) Insider Pooja Sharma Sells 4,710 Shares of Company Stock2 hours agoGlobalFoundries (NASDAQ:GFS) Director Ganesh Moorthy Purchases 2,500 Shares of StockMarketBeatNASDAQ:GFSRead GlobalFoundries (NASDAQ:GFS) Director Ganesh Moorthy Purchases 2,500 Shares of Stock2 hours agoEl Pollo Loco (NASDAQ:LOCO) Stock: Insider Sardar Biglari Sells 5,984 SharesMarketBeatNASDAQ:LOCORead El Pollo Loco (NASDAQ:LOCO) Stock: Insider Sardar Biglari Sells 5,984 Shares2 hours agoEl Pollo Loco (NASDAQ:LOCO) Major Shareholder Sardar Biglari Sells 13,169 Shares of StockMarketBeatNASDAQ:LOCORead El Pollo Loco (NASDAQ:LOCO) Major Shareholder Sardar Biglari Sells 13,169 Shares of Stock2 hours agoAudioeye (NASDAQ:AEYE) Chairman Sells $284,406.48 in StockMarketBeatNASDAQ:AEYERead Audioeye (NASDAQ:AEYE) Chairman Sells $284,406.48 in Stock2 hours agoInsider Selling: Jazz Pharmaceuticals (NASDAQ:JAZZ) CAO Sells 1,413 Shares of Company StockMarketBeatNASDAQ:JAZZRead Insider Selling: Jazz Pharmaceuticals (NASDAQ:JAZZ) CAO Sells 1,413 Shares of Company Stock2 hours agoJELD-WEN (NYSE:JELD) Stock: Insider Turtle Creek Asset Management Sells 300,000 SharesMarketBeatNYSE:JELDRead JELD-WEN (NYSE:JELD) Stock: Insider Turtle Creek Asset Management Sells 300,000 Shares2 hours agoPorch Group (NASDAQ:PRCH) Stock: Insider Matt Ehrlichman Sells 19,452 SharesMarketBeatNASDAQ:PRCHRead Porch Group (NASDAQ:PRCH) Stock: Insider Matt Ehrlichman Sells 19,452 Shares2 hours agoInsider Selling: Abbott Laboratories (NYSE:ABT) EVP Sells 3,500 Shares of Company StockMarketBeatNYSE:ABTRead Insider Selling: Abbott Laboratories (NYSE:ABT) EVP Sells 3,500 Shares of Company Stock2 hours agoInsider Selling: Sprouts Farmers Market (NASDAQ:SFM) CEO Sells $584,062.32 in StockMarketBeatNASDAQ:SFMRead Insider Selling: Sprouts Farmers Market (NASDAQ:SFM) CEO Sells $584,062.32 in Stock2 hours agoInsider Selling: HCA Healthcare (NYSE:HCA) EVP Sells 1,200 Shares of Company StockMarketBeatNYSE:HCARead Insider Selling: HCA Healthcare (NYSE:HCA) EVP Sells 1,200 Shares of Company Stock2 hours agoAppFolio (NASDAQ:APPF) Major Shareholder Maurice Duca Sells 3,200 Shares of StockMarketBeatNASDAQ:APPFRead AppFolio (NASDAQ:APPF) Major Shareholder Maurice Duca Sells 3,200 Shares of Stock2 hours agoAvery Dennison (NYSE:AVY) Director Sells $775,200.00 in StockMarketBeatNYSE:AVYRead Avery Dennison (NYSE:AVY) Director Sells $775,200.00 in Stock2 hours agoSiBone (NASDAQ:SIBN) SVP Michael Pisetsky Sells 36,241 Shares of Company StockMarketBeatNASDAQ:SIBNRead SiBone (NASDAQ:SIBN) SVP Michael Pisetsky Sells 36,241 Shares of Company Stock2 hours agoAppFolio (NASDAQ:APPF) Major Shareholder Sells 3,800 Shares of Company StockMarketBeatNASDAQ:APPFRead AppFolio (NASDAQ:APPF) Major Shareholder Sells 3,800 Shares of Company Stock Featured Articles and OffersAbbVie's Humira Era Is Fading, But Its New Growth Engines Face Another TestBy Thomas Hughes | November 2, 2026Financial legend: “This is bad, really bad...”From Weiss Ratings (Ad)Marriott's Earnings Beat Shows Why It's More Than a Bet on Travel DemandBy Chris Markoch | November 3, 2026Why JFrog Could Be the Software Infrastructure Company to Beat in the AI BoomBy Nathan Reiff | October 31, 2026Marvell Eyes a Swing for the AI Networking Fences as Markets Weigh Lumentum Price TagBy Leo Miller | November 1, 2026$809B man set to shock investors for a 10th timeFrom StocksToTrade (Ad)3 Waste Services Stocks With More Growth Than You Might ExpectBy Nathan Reiff | November 2, 2026Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double DigitsBy Bridget Bennett | November 2, 2026 Alert CategoriesAll AlertsAnalystCongressional TradesConsensusCorporate BuybackCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeLockup ExpirationMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Page 1 of 513 1234567 Earlier › Earliest » Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
